Bureau for Democracy, Conflict and Humanitarian Assistance Bureau for Economic Growth, Agriculture, and Trade Bureau for Global Health Bureau for Management Bureau for Policy and Program Coordination Global Development Alliance International Partnerships Summary Tables Abbreviations & Acronyms Last updated: Wednesday, 29-May-2002 18:53:12 EDT

Within the Development Assistance account, $226.5 millin is requested in FY 2003 for international health partnerships: HIV/AIDS $173 million; and Child Survival and Maternal Health $53.5 million, compared with a total of $177.25 in FY 2002.

HIV/AIDS and Infectious Diseases: FY 2002 $118 million; FY 2003 $173 million

The Global Fund for AIDS, Tuberculosis and Malaria (GFATM) has been established by a group of international public and private sector partners to leverage increased resources to support prevention and treatment programs in the fight against the three diseases. The fund will support an integrated approach to combating the diseases, combining prevention, treatment and care. Current GFATM partners include bilateral donors, multilateral agencies, private foundations, NGOs and developing country representatives. USAID requests $100 million for the Global Fund for FY 2003; USAID will provide $150 million in FY 2002 ($100 million from FY 2001 and $50 million from FY 2002).

USAID requests $15 million in FY 2003 for the development of microbicides for the prevention of HIV/AIDS and sexually transmitted diseases. USAID has been partnering with both U.S. Government and international partners to ensure a coordinated effort to develop an effective microbicide. As a part of these efforts, U.S. Government agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Health Resources and Services Administration, have generated a comprehensive plan to support microbicide development, with all U.S. Government partner contributions totaling $35 million in FY 2003. USAID plans to provide $15 million in FY 2002 for this purpose.

In addition, $58 million is requested in FY 2003 for both on-going and new partnerships. Examples of ongoing partnerships are the International AIDS Vaccine Initiative (IAVI) and the Joint United Nations Program on HIV/AIDS (UNAIDS). The goal of IAVI is to leverage and apply resources toward the global effort to develop an AIDS vaccine. UNAIDS provides global leadership and promotes consensus on policy and programmatic approaches to fighting the HIV/AIDS pandemic. UNAIDS strengthens national government programs by assisting them in the development of apropriate HIV/AIDS policies and strategies. USAID will provide $53 million in FY 2002 for these partnerships.

Child Survival and Maternal Health: FY 2002 $59.25 million; FY 2003 $53.5 million

USAID requests $50 million in FY 2003 for the Global Alliance for Vaccines and Immunization (GAVI) Vaccine Fund; USAID will provide $53 million in FY 2002. The goal of GAVI is to increase the availabilit of essential life-saving vaccines in developing countries. Strategic objectives shared by GAVI partners are to improve access to and expand use of vaccines, accelerate vaccine research and development, and make immunization coverage a centerpiece in the design and assessment of international development efforts.

In FY 2003, USAID requests $3.5 million for the Global Alliance for Improved Nutrition (GAIN). GAIN is a newly formed alliance of public and private sector organizations seeking to improve health through the elimination of vitamin and mineral deficiencies. Gain was founded by initial pledges from USAID, the Bill and Melinda Gates Foundation, and the Canadian International Development Agency. GAIN's primary strategy will be to provide grants to developing countries in support of commercially sustainable food fortification programs. GAIN partners include bilateral donors, foundations, multilateral agencies and private sector organizations. In FY 2002, USAID's overall funding for micronutrient deficiencies is $6.25 million.